These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30066239)

  • 1. Selective inhibition of P-gp transporter by goniothalamin derivatives sensitizes resistant cancer cells to chemotherapy.
    Sachs J; Kadioglu O; Weber A; Mundorf V; Betz J; Efferth T; Pietruszka J; Teusch N
    J Nat Med; 2019 Jan; 73(1):226-235. PubMed ID: 30066239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, in silico and in vitro studies of new 1,4-dihydropiridine derivatives for antitumor and P-glycoprotein inhibitory activity.
    Mollazadeh S; Sahebkar A; Kalalinia F; Behravan J; Hadizadeh F
    Bioorg Chem; 2019 Oct; 91():103156. PubMed ID: 31416030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.
    Binkhathlan Z; Lavasanifar A
    Curr Cancer Drug Targets; 2013 Mar; 13(3):326-46. PubMed ID: 23369096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
    Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
    Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of P-glycoprotein-mediated multidrug resistance by natural N-alkylated indole alkaloid derivatives in KB-ChR-8-5 drug-resistant cancer cells.
    Bharathiraja P; Cardoso DSP; Rajendra Prasad N; Mulhovo S; Lakra DS; Ferreira MU
    J Biochem Mol Toxicol; 2023 Sep; 37(9):e23421. PubMed ID: 37345739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.
    Li YS; Yang X; Zhao DS; Cai Y; Huang Z; Wu R; Wang SJ; Liu GJ; Wang J; Bao XZ; Ye XY; Wei B; Cui ZN; Wang H
    Eur J Med Chem; 2021 Apr; 216():113336. PubMed ID: 33725657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
    Hou W; Meng Y; Xu XF; Huang ZX; Liu J; Wang ZY; Lin J; Chen WM
    Eur J Med Chem; 2019 Dec; 183():111726. PubMed ID: 31585275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update.
    Dong J; Qin Z; Zhang WD; Cheng G; Yehuda AG; Ashby CR; Chen ZS; Cheng XD; Qin JJ
    Drug Resist Updat; 2020 Mar; 49():100681. PubMed ID: 32014648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of P-glycoprotein mediated multidrug resistance by stemofoline derivatives.
    Umsumarng S; Pintha K; Pitchakarn P; Sastraruji K; Sastraruji T; Ung AT; Jatisatienr A; Pyne SG; Limtrakul P
    Chem Pharm Bull (Tokyo); 2013; 61(4):399-404. PubMed ID: 23358236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells.
    Teodori E; Braconi L; Bua S; Lapucci A; Bartolucci G; Manetti D; Romanelli MN; Dei S; Supuran CT; Coronnello M
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32290281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp).
    Zhang H; Xu H; Ashby CR; Assaraf YG; Chen ZS; Liu HM
    Med Res Rev; 2021 Jan; 41(1):525-555. PubMed ID: 33047304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
    Li H; Krstin S; Wink M
    Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment.
    Waghray D; Zhang Q
    J Med Chem; 2018 Jun; 61(12):5108-5121. PubMed ID: 29251920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.